Being Resilient. That’S Live Enterprise

Total Page:16

File Type:pdf, Size:1020Kb

Being Resilient. That’S Live Enterprise Being Resilient. That’s Live Enterprise. Infosys BPM Limited Annual Report 2019–20 This page is left blank intentionally Board and Committees – Infosys BPM Limited The Board of Directors Board committees Corporate social responsibility committee Ravikumar Singisetti Audit committee Chairman Ravikumar Singisetti Gopal Devanahalli Chairperson Anantharaman Radhakrishnan Chairperson and Financial Expert Managing Director and Chief Executive Officer Anantharaman Radhakrishnan Michael Nelson Gibbs Member Gopal Devanahalli Member Independent Director Gopal Devanahalli Ravikumar Singisetti Member Michael Nelson Gibbs Member Independent Director Investment committee Inderpreet Sawhney Nomination and remuneration committee Ravikumar Singisetti Director Gopal Devanahalli Chairperson Chairperson Anantharaman Radhakrishnan Michael Nelson Gibbs Member Member Prem Joseph Pereira Ravikumar Singisetti Member Member As on April 1, 2020 Infosys BPM Limited Annual Report 2019-20 This page is left blank intentionally Contents Board’s report . 1 Annexures to the Board’s report . 13 Corporate governance report . 30 Management’s discussion and analysis . 39 Risk management report . 54 Report on health, safety and environment . 56 CEO and CFO certification . .. 58 Standalone financial statements . 59 Consolidated financial statements . .. 104 Ratio analysis . .. 153 Global presence . .. 154 Notice to the 18th Annual General Meeting . 157 Infosys BPM Limited Annual Report 2019-20 This page is left blank intentionally Board’s report Dear members, The Board of Directors hereby submits the report of the business and operations of Infosys BPM Limited (“the Company”), along with the audited financial statements, for the financial year ended March 31, 2020. The consolidated performance of the Company and its subsidiaries (“the Group”) has been referred to wherever required. 1 . Results of our operations and state of affairs In ` crore, except per equity share data Particulars Standalone Consolidated For the year ended For the year ended March 31, March 31, 2020 2019 2020 2019 Revenue from operations 4,595 3,932 6,922 6,022 Cost of sales 3,439 2,856 5,348 4,558 Gross profit 1,156 1,076 1,574 1,464 Selling and marketing expenses 219 200 235 212 General and administration expenses 337 318 519 494 Operating profit 556 558 820 758 Other income, net 290 225 279 211 Financial cost (32) – (41) – Profit before tax 858 783 1,058 969 Tax expenses 210 187 252 252 Profit for the year 648 596 806 717 Other comprehensive income Items that will not be reclassified subsequently to profit or loss (3) (4) (6) (13) Items that will be reclassified subsequently to profit or loss 6 1 46 (23) Total other comprehensive income, net of tax 3 (3) 40 (36) Total comprehensive income for the year 651 593 846 681 Earnings per share (EPS) (1) Basic 191.61 176.30 238.23 211.88 Diluted 191.61 176.30 238.23 211.88 Notes: The above figures are extracted from the audited standalone and consolidated financial statements as per Indian Accounting Standards (Ind AS). 1 crore = 10 million (1) Equity shares are at par value of ` 10 per share. Infosys BPM Limited Annual Report 2019-20 Board’s report I 1 Financial position in ` crore, except equity share and per equity share data Particulars Standalone Consolidated 2020 2019 2020 2019 Cash and cash equivalents 2,274 1,837 3,137 2,627 Current investments 630 535 630 535 Net current assets 3,260 2,673 4,081 3,484 Property, plant and equipment (including capital work-in- progress) 214 239 281 271 Right to use assets 427 – 836 – Goodwill 19 19 406 394 Other intangible assets – – 5 13 Other non-current assets 108 77 141 145 Total assets 6,168 4,848 8,677 6,677 Non-current liabilities 419 11 843 57 Retained earnings – opening balance 4,000 3,407 4,768 4080 Add : Profit for the year 648 596 806 717 Exchange differences on translation foreign operations and re-measurement differences 3 (3) 40 (36) Reserves created on account of common control business acquisition – – – 7 Transfer from Special Economic Zone Re-investment Reserve on utilization 71 66 71 66 Less : Impact on account of adoption of Ind AS 116 (19) – (8) – Transfer to Special Economic Zone Re-investment Reserve(1) (71) (66) (71) (66) Retained earnings – closing balance 4,632 4,000 5,479 4,768 Other equity 34 34 34 34 Total equity 4,666 4,034 5,513 4,802 Total equity and liabilities 6,168 4,848 8,677 6,632 Number of equity shares 3,38,27,751 3,38,27,751 3,38,27,751 3,38,27,751 (1) The Special Economic Zone (SEZ) Re-investment Reserve has been created out of the profit of eligible SEZ units in terms of the provisions of Section 10AA(1)(ii) of the Income-tax Act, 1961. The reserve should be utilized by the Company for acquiring new plant and machinery for the purpose of its business in the terms of Section 10AA(2) of the Income-tax Act, 1961 2 I Board’s report Infosys BPM Limited Annual Report 2019-20 Company’s overview and by enhancing experience for their stakeholders through Infosys BPM Limited, (IBPM), formerly Infosys BPO Limited, our approach of digital automation to amplify business the business process management subsidiary of Infosys productivity and efficiency, insights to improve business Limited, provides end-to-end transformative services to outcomes and effectiveness and innovation to enhance its clients globally. The company’s integrated IT and BPM stakeholder delight and experience. The Company has also solutions approach drives optimized outcomes and enables it been consistently ranked among the top employers of choice, to unlock business value across industries and service lines, on the basis of its industry leading HR practices. address business challenges for its clients helping them Performance overview (Standalone) navigate their next. The primary focus for IBPM is to enable Our revenues from operations aggregated to ` 4,595 crore, its clients to achieve their cost reduction objectives, improve up by 16.9% from ` 3,932 crore in the previous year. Our process efficiencies, enhance effectiveness, and deliver gross profits amounted to ` 1,156 crore as against ` 1,076 superior customer experience crore in the previous year. The operating profits amounted Infosys BPM Limited is a leader in providing innovative to ` 600 crore as against ` 558 crore in the previous year. solutions to its clients in today’s ever-changing technology Sales and marketing costs were ` 219 crore and ` 200 crore landscape through traditional, digital service offerings, for the years ended March 31, 2020 and March 31, 2019 vertical utility platforms and shared service center models. respectively. General and administration expenses were ` 337 Whether it is about utilizing innovative business excellence crore and ` 318 crore during the current year and previous frameworks, ongoing productivity improvements, process year respectively. Net profits after tax stood at ` 648 crore as reengineering, automation, and cutting-edge technology against ` 596 crore in the previous year. The profit after tax platforms, we are able to consistently add value to our clients. for the year was 14.1% of revenue. Our traditional BPM service offerings, are complemented by our Digital Business offerings – Digital Transformation Performance overview (Consolidated) Services and Digital Interactive Services. While the Group’s Our revenues from operations aggregated to ` 6,922 crore, joint venture with Hitachi, Panasonic and Pasona in Japan up by 14.9% from ` 6,022 crore in the previous year. Our enhances our traditional enterprise services in sourcing and gross profits amounted to ` 1,574 crore as against ` 1,464 procurement; our platform-based digital capabilities were crore in the previous year. The operating profits amounted to further enriched in insurance with the launch of McCamish ` 820 crore as against ` 758 crore in the previous year. Sales NGIN, our modernized insurance platform for global life and marketing costs were ` 235 crore and ` 212 crore for the insurance and annuity; and in mortgage platform servicing years ended March 31, 2020 and March 31, 2019 respectively. capabilities through the Group’s acquisition of ABN Amro General and administration expenses were ` 519 crore and Bank’s wholly-owned subsidiary – Stater NV. ` 494 crore during the current and previous year, respectively. Infosys BPM Limited continues to be ranked leaders across Net profits after tax were ` 806 crore as against ` 717 crore industry utilities such as Insurance, Mortgage, Banking, in the previous year. The Group’s profit after tax for the year Healthcare, Capital Markets, Financial Services, Energy, is 11.6% of revenue. Manufacturing, Telecom and Retail; across enterprise offerings The Company continues to be amongst the most profitable such as Finance & Accounting, Sourcing and Procurement BPM companies in India. The Company has 212 customers as and Human Resources Outsourcing as well as Digital on March 31, 2020. The Company ended FY20 with 42,157 offerings such as Digital Interactive Services, Analytics, RPA employees across 122 nationalities. and Artificial Intelligence (AI) by leading analysts such as The financial year 2020 was a very productive and significant Nelsonhall, Gartner, Everest, HfS, ISG and IDC. one for Infosys BPM Limited since we won multiple new Your Company seeks to differentiate in the market by logos which include a UK-based multinational professional navigating clients to experience their next by delivering services firm, a Europe-based and a US-based mortgage business value through deep domain expertise and technology services provider and a Europe-based logistics and supply prowess. We invest in offerings that help clients optimize their chain company among others. The company also entered into Cost of Revenues (CoR) instead of the traditional approach a strategic partnership with Eishtec, one of Ireland’s leading of optimizing just the Selling, General and Administrative customer service providers. This included transfer of Eishtec’s (SG&A) expenses.
Recommended publications
  • 50 KW Offer Solar Copy 2
    21st Century Enviro Engineers Pvt.Ltd. Plot No. 120(10 Marla), COMPANY Industrial Area Phase II Chandigarh - 160002, India PROFILE www.21stcenturyenviro.com INTRODUCTION 21st CENTURY ENVIRO ENGINEERS PVT. LTD. is a Company dealing in the field of Environmental Engineering related activities. We are Registered Environmental Consultants of Pollution Control Board to Supply ETP’s, STP’s, APCD’s, Incinerators, Water Treatment Plants, Reverse Osmosis, Evaporators, Solid Waste Management and Rain Water Harvesting and to carry out EIA Studies . The Directors of the company are young Technocrats having versatile experience in this field. We have a back up of highly qualified and experienced technical team having versatile experience in Designing, Erection, Commissioning and Operation of different types of Effluent Treatment Plants. Our Managing Director himself is a Chemical Engineer with almost 25 Years Experience in this line and Technical Director is PhD. in Environmental Science with almost 30 Years working experience on various types of effluent treatment Technologies. Our team comprises of almost 150 people from different backgrounds e.g. Chemical, Environmental, Mechanical, Instrumentation, Civil, Accounts, Purchase, Marketing etc. We have our Marketing/ Design Office in Chandigarh and regional offices in Dhaka, Mumbai, New Delhi, Sikkim etc. and have our own testing Laboratory for Effluent/Water Testing and to study treatability of effluent on pilot scale. We have our own full-fledged manufacturing unit of Pollution Control Equipments in Village Kunjhal Baddi (HP). We also undertake annual operation and maintenance contracts and liasining services for the systems supplied by us. We are also Registered with CREST (Chandigarh Renewable Energy & Technology Promotion Society) and SECI (Solar Energy Corporation of India) for supplying Online/Offline Solar systems in Chandigarh, Himachal Pradesh, Uttarakhand, J&K, Punjab, Haryana, Delhi, Bihar etc.
    [Show full text]
  • Glenmark Pharmaceuticals (GLEPHA)
    Glenmark Pharmaceuticals (GLEPHA) CMP: | 483 Target: | 560 (16%) Target Period: 12 months BUY August 17, 2020 Subdued topline; margin expansion to the fore… Revenues stayed flattish growing just 0.9% YoY to | 2345 crore due to subdued growth of 1.6% in US to | 743 crore, 3.7% growth in domestic sales to | 780 crore. Europe business grew 12.8% YoY to | 274 crore. RoW markets de-grew 18.1% YoY to 212 crore. EBITDA margins improved 567 bps YoY to 20.4% mainly due to lower other expenditure. EBITDA grew Particulars 39.8% YoY to | 478 crore. Adjusted PAT grew 106.9% YoY to | 226 crore. P articular Am ount Delta vis-à-vis EBITDA was due to higher other income. Exceptional items in Market Capitalisation | 13615 crore Q1FY21 were | 28 crore on gain arising from sale of Vwash brand to HUL. Debt (FY20) | 4868 crore Result Update Result Cash & equivalent (FY20) | 1111 crore US growth dependent on new launches E V | 17371 crore 52 week H/L (|) 573/168 US generics comprise ~30% of total revenues. So far, the company has E quity capital | 28.2 crore Face value | 1 received approval for 164 ANDAs while another 44 are pending approval, of which 24 are Para IV applications. However, Glenmark’s derma portfolio is Key Highlights facing stiff pricing pressure in the US. Going ahead, traction from the newly commissioned US based Monroe facility will be the key determinant besides Q1FY21 revenues remained flattish sustained product launches. We expect the US to grow at 5.2% CAGR in due to subdued US growth amid FY20-22E to | 3479 crore on the back of new launches.
    [Show full text]
  • Hy Sun Missed the Pharma Rally: the Answer Is Hidden in a Bet Many Failed — Speciality Drugs - the Economic Times
    12/3/2020 Sun Pharma: Why Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs - The Economic Times Home ETPrime Markets News Industry RISE Politics Wealth MF Tech Jobs Opinion NRI Panache ET NOW More Aayush English Edition | E-Paper Tech Consumer Markets Corporate Governance Telecom + OTT Auto + Aviation Pharma Fintech + BFSI Economy Infra Environment Energy Business News › Prime › Pharma › Why Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs Getty Images MARKETS hy Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs Dilip Shanghvi, founder and managing director, Sun Pharmaceuticals Synopsis Sun Pharma is the only Indian company to have made some inroads into speciality drugs. What worries investors is high investments and uncertainties over ramp up in revenue. The stock can still see upside because of its current valuations, strong India business, and any positive surprises in US generic business. But it is crucial that its speciality bet pays off. BACK TO TOP https://economictimes.indiatimes.com/prime/pharma-and-healthcare/why-sun-missed-the-pharma-rally-the-answer-is-hidden-in-a-bet-many-failed-spe… 1/11 12/3/2020 Sun Pharma: Why Sun missed the pharma rally: the answer is hidden in a bet many failed — speciality drugs - The Economic Times Home ETPrime Markets NeCwasllI nitd uas trbyleRssISiEngP oilniti cdsisWgeuailthse fMoFr tTheceh InJodbisanOpinion NRI Panache ET NOW More pharmaceutical industry. The stocks of pharma companies have been on a tear since the beginning of the Covid-19 crisis.
    [Show full text]
  • DIA India ICH Day 2019 Enhancing Clinical Trial Outcomes with ICH 30Th August, 2019 | Taj Lands End | Mumbai, India
    DIA India ICH Day 2019 Enhancing Clinical Trial Outcomes with ICH 30th August, 2019 | Taj Lands End | Mumbai, India PROGRAMME COMMITTEE Today, the Indian pharmaceutical industry supplies approximately 20% of the world’s generic drugs and has the largest number of FDA-approved manufacturing facilities C. Michelle Limoli outside of the US. This industry has evolved during the past decade into innovative drug Senior International development, including new chemical and biological entities, biosimilars, and innovative Health Science Advisor differentiated products. At the same time, as healthcare costs continue to rise across the US FDA world, so does the global need for affordable, innovative healthcare. Against this backdrop, DIA India aims to create an initiative that will address the clinical and regulatory aspects Ramesh Jagannathan of drug development, through a comprehensive single day workshop on the latest ICH Associate Vice President guidelines and developments relevant for India. - R&D Biocon Ltd. Objective Anupama Ramkumar CEO and Principal The objective of this program is to provide a common platform for ICH trainers, regulatory Consultant authorities, academia, investigators, service providers, and the Indian biopharmaceutical Arkus Research Pvt. Ltd. industry, to deliberate upon and understand ICH guidelines and the most recent updates, impacting the drug development spectrum including key clinical, regulatory and quality Seema Pai aspects. Director - India Cluster Global Site & Study Take a look at our key topics for the event
    [Show full text]
  • Company Reliance Industries Limited Tata Consultancy Services
    Top 1000 Private Sector Companies (Rank-wise List) Company Reliance Industries Limited Tata Consultancy Services (TCS) Infosys Technologies Ltd Wipro Limited Bharti Tele-Ventures Limited ITC Limited Hindustan Lever Limited ICICI Bank Limited Housing Development Finance Corp. Ltd. TATA Steel Limited Ranbaxy Laboratories Limited HDFC Bank Ltd Tata Motors Limited Larsen & Toubro Limited (L&T) Satyam Computer Services Ltd. Maruti Udyog Limited Bajaj Auto Ltd. HCL Technologies Ltd. Hero Honda Motors Limited Hindalco Industries Ltd Reliance Energy Limited Grasim Industries Limited Jet Airways (India) Ltd. Sun Pharmaceuticals Industries Ltd Cipla Ltd. Gujarat Ambuja Cements Ltd. Videsh Sanchar Nigam Limited The Tata Power Company Limited Sterlite Industries (India) Ltd. Associated Cement Companies Ltd. Nestlé India Ltd. Hindustan Zinc Limited GlaxoSmithKline Pharmaceuticals Limited Siemens India Ltd. Motor Industries Company Limited Mahindra & Mahindra Limited UTI Bank Ltd. Zee Telefilms Limited Bharat Forge Limited ABB Limited i-Flex Solutions Ltd. Dr. Reddy's Laboratories Ltd. Nicholas Piramal India Limited Kotak Mahindra Bank Limited Reliance Capital Ltd. Ultra Tech Cement Ltd. Patni Computer Systems Ltd. Wockhardt Limited Indian Petrochemicals Corporation Limited Biocon India Limited Essar Oil Limited. Asian Paints Ltd. Dabur India Limited Jaiprakash Associates Limited JSW Steel Limited Tata Chemicals Limited Tata Tea Limited Tata Teleservices (Maharashtra) Limited The Indian Hotels Co. Ltd. Glenmark Pharmaceuticals Limited NIRMA Limited Jindal Steel & Power Ltd HCL Infosystems Ltd. Cadila Healthcare Limited Colgate-Palmolive (India) Limited The Great Eastern Shipping Company Limited Aventis Pharma India Ltd Ashok Leyland Limited Pantaloon Retail (India) Limited Indian Rayon And Industries Limited Financial Technologies (India) Ltd United Phosphorus Limited Matrix Laboratories Limited Sesa Goa Limited Lupin Ltd Cummins India Limited Crompton Greaves Limited.
    [Show full text]
  • Final Placement Report 2020-21
    FINAL PLACEMENT REPORT POST GRADUATE ProgrAM IN MANAGEMENT (PGP) 2019-21 12th BAtcH INDIAN INSTITUTE OF MANAGEMENT SHILLONG FOREWORD The Placement Committee of IIM Shillong takes immense pride in announcing the successful completion of the final placement season for the PGP batch of 2019-21. The stellar performance by the PGP participants stands testimony to the rapid progress made by IIM Shillong and has once again established IIM Shillong as the preferred choice for recruiters. We express our gratitude to our regular recruiters who have continuously believed in the mettle of our students and have furthered their association with us for another year to facilitate this mutually beneficial relationship. We are also grateful to our new recruiters, who have acknowledged the potential of our students and provided them with a plethora of opportunities. We appreciate the contribution of the entire IIM Shillong fraternity for their sustained assistance in the placement process. With continued support from students, recruiters, faculty, alumni, staff and management, we hope to carry this momentum onto the next academic year. Prof. Rohit Joshi Chairperson Placement Committee IIM Shillong BATCH PROFILE OF 2019-21 Education Background 9% 9% 9% 57% 198 16% Number 61% 39% of Students Male Female Engineering Arts Commerce & Finance Others Science Work Experience by Months Domain wise Work Experience Freshers 27% Information Technology & Analytics 47% 01-12 months 23% Consulting & Strategy 13% 19% Finance 23% 13-24 months 18% Sales & Marketing 11% 25-36
    [Show full text]
  • Stocks to Watch: Dish TV, Eicher, M&M
    Stocks to Watch: Dish TV, Eicher, M&M, Metropolis Health, Sun Pharma Friday, May 28, 2021 - Morning brief for the stock market: TOP EVENTS TODAY * Nifty 50 company detailing Jan-Mar earning: + Mahindra & Mahindra and Mahindra Vehicle Manufacturers, (Net profit seen 10.97 bln rupees vs 32.6 bln rupees loss year ago) * Jan-Mar earnings to be detailed by: 3M India, Incon Engineers, Rolcon Engineering Co, Action Construction Equipment, India Nippon Electricals, RSWM, AD Manum Finance, Indian Bank, Servoteach Industries, Aditya Birla Fashion and Retail, Indokem, Sharp Investments, Ador Multiproducts, IPCA Laboratories, Shish Industries, Ador Welding, ITD Cementation India, Shree Rama Newsprint, 1 Arvind Smartspaces, Jagran Prakashan, Shree Steel Wire Ropes, Associated Alcohols & Breweries, Jindal Poly Films, Shree Tulsi Online.Com, Aurionpro Solutions, Kama Holdings, Si Capital & Financial Services, Batliboi, Kanoria Chemicals & Industries, Sikozy Realtors, Bengal & Assam Co, Karur Vysya Bank, Sirca Paints India, Kovilpatti Lakshmi Roller Flour Blue Circle Services, SMS Pharmaceuticals, Mills, Lakshmi Electrical Control Bridge Securities, SRG Housing Finance, Systems, Calcom Vision, Max Healthcare Institute, SRU Steels, Camlin Fine Sciences, Mindteck India, Stanpacks India, Central Bank of India, Munoth Communication, Steel Exchange India, Chemo Pharma Laboratories, Munoth Financial Services, Steelcast, City Union Bank, NACL Industries, Sudal Industries, Classic Filaments, Navkar Corp, Sudarshan Chemical Industries, Confidence Futuristic Energetech,
    [Show full text]
  • In the United States District Court for the District of Delaware
    IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE NOVARTIS PHARMACEUTICALS CORPORATION Plaintiff, v. Civil Action No. _____ APOTEX INC., APOTEX CORP., BIONPHARMA INC., EMCURE PHARMACEUTICALS, HERITAGE PHARMACEUTICALS INC., EZRA VENTURES, LLC, GLENMARK PHARMACEUTICALS INC., USA, GLENMARK PHARMACEUTICALS LIMITED, HEC PHARM CO., LTD., HEC PHARM USA INC., HETERO USA INC., HETERO LABS LIMITED UNIT-V, HETERO LABS LIMITED, PRINSTON PHARMACEUTICAL INC., STRIDES GLOBAL PHARMA PRIVATE LIMITED, STRIDES PHARMA, INC., ZYDUS PHARMACEUTICALS (USA) INC., and CADILA HEALTHCARE LIMITED Defendants. COMPLAINT Novartis Pharmaceuticals Corporation (“Novartis”) by its attorneys hereby alleges as follows: NATURE OF THE ACTION 1. This is an action for patent infringement arising under the patent laws of the United States, Title 35, United States Code and for declaratory judgment pursuant to the Declaratory Judgment Act, 28 U.S.C. §§ 2201, et seq . This action relates to Abbreviated New Drug Applications (“ANDAs”) filed by the above-named defendants with the U.S. Food and Drug Administration (“FDA”) for approval to engage in the commercial manufacture, use, or sale of Fingolimod 0.5 mg capsules, generic versions of Novartis’s GILENYA ® Capsules, 0.5 mg, prior to expiration of U.S. Patent No. 10,543,179 (“the ’179 patent”). ME1 32500579v.1 PARTIES A. Novartis 2. Novartis Pharmaceuticals Corporation is a corporation organized and existing under the laws of the State of Delaware, with its principal place of business in East Hanover, New Jersey. B. The Generic Defendants a) Apotex Inc.; Apotex Corp. 3. Upon information and belief, Defendant Apotex Inc. is a corporation organized and existing under the laws of Canada, having a principal place of business at 150 Signet Drive, Toronto, Ontario, Canada M9L 1T9.
    [Show full text]
  • Cipla Limited
    Cipla Limited Registered Office: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai – 400 013 Phone: (9122) 2482 6000, Fax: (9122) 2482 6893, Email: [email protected], Website: www.cipla.com Corporate Identity Number: L24239MH1935PLC002380 Annexure to the Board’s Report Particulars of employee remuneration for the financial year ended 31st March, 2017 As required under section 197(12) of the Companies Act, 2013, read with rule 5(2) and (3) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014. Employed throughout the year Name Designation Qualification Experience Age Date of Last employment Remuneration (in years) (in years) Employment (`) Abhayan Jawaharlal CLO - International B.Com, LLB 18 45 03-09-2012 Biocon Group 12,009,351 Ajay Luharuka Head - IPD and API Finance B.Com, MMS, CFA 21 44 11-07-1996 NIIT Limited 12,800,997 Anil Kumar Kartha Site Head - Patalganga B. Sc., B. Pharm 26 54 27-05-1991 Vysali Pharmaceuticals 12,779,636 Anita S Desai Head - Formulations ADL B. Sc., PGCT 22 49 18-07-1994 Bombay Drug House 11,775,986 Anuj Aggarwal Regional Head - EU B. Tech., MBA 13 35 08-07-2013 Mckinsey & Company 13,664,962 Anupam Kashiv Head - Shared Services MPBSE 27 51 18-11-2013 Cadbury Business Services 27,837,834 Balwinder Singh Sethi Regional Head – MENA M.A 19 52 09-01-2012 Promed Exports Pvt Ltd 15,543,864 Chandru Chawla Global Head - CNV, Strategy and B. Tech., PG 29 51 12-12-2011 Lupin Limited 33,920,416 M&A Debashis Sarkar Head - Marketing and APAC DTM B.
    [Show full text]
  • Joindre Capital Services Ltd. Sebi Regn No
    JOINDRE CAPITAL SERVICES LTD. SEBI REGN NO. INH000002061 / INZ000174034 DAILY REPORT 10th August 2018 India to release June industrial production; RBI to hold govt bonds, term repo, reverse repo auctions; State Bank of India, GAIL India, Hindalco Industries, Bosch India, Glenmark Pharmaceuticals, Indraprastha Gas, Sun TV among companies to report earnings. Prime Minister Narendra Modi, Oil Minister Dharmendra Pradhan to speak. WHAT TO WATCH: * India to Sell 3.49m Tons of Pulses to States at Subsidized Rates * India Must Name Chief Statistician At the Earliest, Panel Says * Vedanta Wins 41 blocks, ONGC 2 in Open Acreage Auction: Pradhan ** Vedanta’s Zambia Copper Unit Halts Section of Mine After Death * India Fraud Agency Arrests Former Bhushan Steel MD Neeraj Singal * Essar Signs 15-Year Gas Supply Contract With Gail: Statement * Power-Plant Lender in India Seeks $1 Billion in Dollar Bond Sale * Jet Air in Talks With Staff on Payroll Restructuring, Dube Says * Jet Airways Postpones Results Following Report of Cash Crunch * Templeton Favors Options to Ride Asia’s Best Stock Market Swings * Cryptokidnapping, or How to Lose $3 Billion of Bitcoin in India * The Leaders and Laggards Behind India’s World-Beat Growth * Modi’s Party Mulls Expanding Contentious India Citizenship Rules * Asia Stocks Edge Lower; Dollar Holds Advance: Markets Wrap * Global Funds Buy Net INR7.66b of India Equity Derivatives Thursday ** Global Funds Buy Net 3.71B Rupees of India Stocks Thursday: NSE ** Foreign Investors Buy Net INR9.17b of Indian Equities on Aug. 8 ECONOMIC DATA (All times India Time): * 5:30pm: India June Industrial Production y/y, est.
    [Show full text]
  • Annual Return
    FORM NO. MGT-7 Annual Return [Pursuant to sub-Section(1) of section 92 of the Companies Act, 2013 and sub-rule (1) of (other than OPCs and Small rule 11of the Companies (Management and Companies) Administration) Rules, 2014] Form language English Hindi Refer the instruction kit for filing the form. I. REGISTRATION AND OTHER DETAILS (i) * Corporate Identification Number (CIN) of the company L85110KA1981PLC013115 Pre-fill Global Location Number (GLN) of the company * Permanent Account Number (PAN) of the company AAACI4798L (ii) (a) Name of the company INFOSYS LIMITED (b) Registered office address ELECTRONICS CITY,HOSUR ROAD, BANGALORE KARNATAKA Karnataka 560100 India (c) *e-mail ID of the company [email protected] (d) *Telephone number with STD code 08041167775 (e) Website www.infosys.com (iii) Date of Incorporation 02/07/1981 (iv) Type of the Company Category of the Company Sub-category of the Company Public Company Company limited by shares Indian Non-Government company (v) Whether company is having share capital Yes No (vi) *Whether shares listed on recognized Stock Exchange(s) Yes No Page 1 of 20 (a) Details of stock exchanges where shares are listed S. No. Stock Exchange Name Code 1 National Stock Exchange of India 1,024 2 BSE Limited 1 (b) CIN of the Registrar and Transfer Agent U72400TG2017PTC117649 Pre-fill Name of the Registrar and Transfer Agent KFIN TECHNOLOGIES PRIVATE LIMITED Registered office address of the Registrar and Transfer Agents Selenium, Tower B, Plot No- 31 & 32, Financial District, Nanakramguda, Serilingampally (vii) *Financial year From date 01/04/2020 (DD/MM/YYYY) To date 31/03/2021 (DD/MM/YYYY) (viii) *Whether Annual general meeting (AGM) held Yes No (a) If yes, date of AGM 19/06/2021 (b) Due date of AGM 30/09/2021 (c) Whether any extension for AGM granted Yes No II.
    [Show full text]
  • Sustainability Report 2018-19 to Be a Live Enterprise
    LIVE ENTERPRISE Sustainability Report 2018-19 To be a Live Enterprise The idea of an enterprise likened to a living, breathing organism has been explored for several decades. After all, businesses, like living creatures, are driven by the need to survive, grow and flourish. Not unlike natural selection that fuels the ‘adapt to survive’ response in species, market changes can either drive organizations to navigate to their next innovation, their next advantage, their next business model or to extinction. Today, enterprises are advancing on their digital transformation journey to adapt to rapidly changing markets, business needs and consumer preferences. We help our clients transform their organization to become a Live Enterprise by reimagining the enterprise in a way that strengthens its digital capabilities, progresses its operating model for the digital era and transforms its talent holistically. And we do this through our people and the ecosystems we create for them to learn, innovate and thrive. A ‘Live Enterprise’ is a responsible enterprise. One that continues to earn the respect of its stakeholders – listening, learning and contributing to the overall well-being of the community, leading to a positive impact on the socio-economic landscape of the larger society. Be it in providing access to healthcare and education or influencing the way communities can become self-sustaining, a live enterprise seizes every means of being sustainable and shows the way to others. Global warming and the dire threats to the planet and life on the planet call for immediate and effective action. Working towards understanding and mitigating the impact of its business and stakeholders on the larger environment through abstemious use of scarce natural resources, a live organization knows how to respond to the crisis at hand.
    [Show full text]